Cargando…

Cryptotanshinone inhibits IgE-mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine-protein kinase phosphorylation in mast cells

Detalles Bibliográficos
Autores principales:	Buyanravjikh, Sumiyasuren, Han, Sora, Lee, Sunyi, Jeong, Ae Lee, Ka, Hye In, Park, Ji Young, Boldbaatar, Ariundavaa, Lim, Jong-Seok, Lee, Myeong-Sok, Yang, Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299195/ https://www.ncbi.nlm.nih.gov/pubmed/34278499 http://dx.doi.org/10.3892/mmr.2021.12283

Ejemplares similares

Eupatolide inhibits the TGF-β1-induced migration of breast cancer cells via downregulation of SMAD3 phosphorylation and transcriptional repression of ALK5
por: Boldbaatar, Ariundavaa, et al.
Publicado: (2017)

Eupatolide inhibits the TGF-β1-induced migration of breast cancer cells via downregulation of SMAD3 phosphorylation and transcriptional repression of ALK5
por: Boldbaatar, Ariundavaa, et al.
Publicado: (2018)

Spleen Tyrosine Kinase Inhibition Modulates p53 Activity
por: Althubiti, Mohammad
Publicado: (2017)

Involvement of Bruton's Tyrosine Kinase in FcεRI-dependent Mast Cell Degranulation and Cytokine Production
por: Hata, Daisuke, et al.
Publicado: (1998)

Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases
por: Pamuk, Omer N, et al.
Publicado: (2010)

Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19
por: Wigerblad, Gustaf, et al.
Publicado: (2023)

Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014)

Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2021)

Role of spleen tyrosine kinase in liver diseases
por: Kurniawan, Dhadhang Wahyu, et al.
Publicado: (2020)

Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma
por: Liu, Qian, et al.
Publicado: (2022)

Pharmacological Inhibition of Spleen Tyrosine Kinase Suppressed Neuroinflammation and Cognitive Dysfunction in LPS-Induced Neurodegeneration Model
por: Kim, Min Woo, et al.
Publicado: (2022)

Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model
por: McAdoo, Stephen P., et al.
Publicado: (2020)

Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis
por: Schneider, Raphael, et al.
Publicado: (2022)

An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis
por: Han, Yingjie, et al.
Publicado: (2018)

Prognostic value of spleen tyrosine kinase in human solid tumors
por: Ni, Beibei, et al.
Publicado: (2018)

Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
por: Schweig, Jonas Elias, et al.
Publicado: (2017)

Brusatol Derivative–34 Attenuates Allergic Airway Inflammation Via Inhibition of the Spleen Tyrosine Kinase Pathway
por: Ding, Yasi, et al.
Publicado: (2021)

Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization
por: Tempest-Roe, Shenzhen, et al.
Publicado: (2022)

High Levels of Receptor Tyrosine Kinases in CCM3-Deficient Cells Increase Their Susceptibility to Tyrosine Kinase Inhibition
por: Sartages, Miriam, et al.
Publicado: (2020)

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
por: Allert, Catana, et al.
Publicado: (2022)

Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia
por: Cheng, Rubin, et al.
Publicado: (2021)

Spleen Tyrosine Kinase Mediates Microglial Activation in Mice With Diabetic Retinopathy
por: Liu, Xiaozhe, et al.
Publicado: (2021)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
por: Li, Mohan, et al.
Publicado: (2023)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
por: Zhou, Yaqi, et al.
Publicado: (2023)

A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells
por: Seo, Hyang-Hee, et al.
Publicado: (2017)

Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
por: Piris-Villaespesa, Miguel, et al.
Publicado: (2020)

Bruton’s Tyrosine Kinase Inhibition Promotes Myelin Repair
por: Martin, Elodie, et al.
Publicado: (2020)

Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
por: Arneson, Laura C, et al.
Publicado: (2021)

Regulation and Function of Syk Tyrosine Kinase in Mast Cell Signaling and Beyond
por: de Castro, Rodrigo Orlandini
Publicado: (2011)

Tyrosine kinase inhibitors as an alternative treatment in canine mast cell tumor
por: Coelho, Yasmin Nascimento Bernardes, et al.
Publicado: (2023)

Characterizing the structure–activity relationships of natural products, tanshinones, reveals their mode of action in inhibiting spleen tyrosine kinase
por: Tung, Min-Che, et al.
Publicado: (2021)

Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection
por: Ullah, Imran, et al.
Publicado: (2023)

A Method for Overcoming Plasma Protein Inhibition of Tyrosine Kinase Inhibitors
por: Young, David J., et al.
Publicado: (2021)

Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase
por: Mattila, Elina, et al.
Publicado: (2010)

Methotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis
por: Coffey, Greg, et al.
Publicado: (2013)

PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers
por: Coffey, Greg, et al.
Publicado: (2016)

Phosphorylation impact on Spleen Tyrosine kinase conformation by Surface Enhanced Raman Spectroscopy
por: Cottat, Maximilien, et al.
Publicado: (2017)

Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression
por: Ni, Beibei, et al.
Publicado: (2016)

The Expression and Clinical Significance of Spleen Tyrosine Kinase in Patients with Coronary Heart Disease
por: Liang, Ke, et al.
Publicado: (2019)

Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy
por: McAdoo, Stephen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ubn05odt75tgr0r3ei5u9r80cf